68GaNOTA-Anti-HER2 VHH1

DRUG2 trials

Sponsors

Universitair Ziekenhuis Brussel

Conditions

Biliary Tract CancerCancer of PancreasCarcinomaCholangiocarcinomaColorectal CancerEndometrial CancerGastric CancerLocally Advanced Breast Cancer

Phase 2

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients

TerminatedNCT03331601

Universitair Ziekenhuis BrusselCarcinoma, Receptor, ErbB-2

Start: 2017-10-16End: 2025-10-14Updated: 2026-06-01

Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

RecruitingNCT03924466

Universitair Ziekenhuis BrusselBiliary Tract Cancer, Cancer of Pancreas, Cholangiocarcinoma +11

Start: 2019-04-01End: 2024-12-31Target: 55Updated: 2024-02-16